ScoreWhy is Godavari Drugs Ltd ?
1
Weak Long Term Fundamental Strength with a -2.98% CAGR growth in Net Sales over the last 5 years
- Low ability to service debt as the company has a high Debt to EBITDA ratio of 5.22 times
2
Flat results in Dec 25
- NET SALES(Q) Lowest at Rs 22.18 cr
- EPS(Q) Lowest at Rs 1.01
3
With ROCE of 9.1, it has a Attractive valuation with a 1.8 Enterprise value to Capital Employed
- The stock is trading at a discount compared to its peers' average historical valuations
- Over the past year, while the stock has generated a return of 30.26%, its profits have fallen by -43.4%
4
Increasing Participation by Institutional Investors
- Institutional investors have increased their stake by 1.97% over the previous quarter and collectively hold 2.47% of the company
- These investors have better capability and resources to analyse fundamentals of companies than most retail investors
5
Market Beating performance in long term as well as near term
- Along with generating 30.26% returns in the last 1 year, the stock has outperformed BSE500 in the last 3 years, 1 year and 3 months
Real-Time Research ReportHow much should you hold?
- Overall Portfolio exposure to Godavari Drugs should be less than 10%
- Overall Portfolio exposure to Pharmaceuticals & Biotechnology should be less than 30%
(If sector exposure > 30%, please use optimiser tool to see which are the best stocks to hold in Pharmaceuticals & Biotechnology)
When to exit? - We will constantly monitor the company and suggest at the appropriate time to exit from the stock
Is Godavari Drugs for you?
High Risk, High Return
Absolute
Risk Adjusted
Volatility
Godavari Drugs
30.26%
0.53
57.61%
Sensex
-7.23%
-0.56
13.01%
Quality
Management Risk
Growth
Capital StructureQuality key factors
Factor
Value
Sales Growth (5y)
-2.98%
EBIT Growth (5y)
1.36%
EBIT to Interest (avg)
2.32
Debt to EBITDA (avg)
3.62
Net Debt to Equity (avg)
1.37
Sales to Capital Employed (avg)
2.09
Tax Ratio
24.39%
Dividend Payout Ratio
0
Pledged Shares
0.21%
Institutional Holding
2.47%
ROCE (avg)
13.39%
ROE (avg)
13.97%
ValuationValuation Key Factors 
Factor
Value
P/E Ratio
37
Industry P/E
35
Price to Book Value
2.99
EV to EBIT
23.66
EV to EBITDA
18.05
EV to Capital Employed
1.84
EV to Sales
1.92
PEG Ratio
NA
Dividend Yield
NA
ROCE (Latest)
9.13%
ROE (Latest)
8.08%
Loading Valuation Snapshot...
TechnicalsTechnical key factors
Indicator
Weekly
Monthly
MACD
Bullish
Bullish
RSI
No Signal
No Signal
Bollinger Bands
Mildly Bullish
Bullish
Moving Averages
Bullish (Daily)
KST
Bullish
Mildly Bullish
Dow Theory
No Trend
Mildly Bullish
Technical Indicator Scale: Bearish, Mildly Bearish, Sideways, Mildly Bullish, Bullish Turned 
Financial Trend0What is working for the Company
NO KEY POSITIVE TRIGGERS
-4What is not working for the Company
NET SALES(Q)
Lowest at Rs 22.18 cr
EPS(Q)
Lowest at Rs 1.01
Loading Valuation Snapshot...
Here's what is not working for Godavari Drugs
Net Sales - Quarterly
At Rs 22.18 cr has Fallen at -15.9% (vs previous 4Q average)
over average Net Sales of the previous four quarters of Rs 26.38 CrMOJO Watch
Near term sales trend is very negative
Net Sales (Rs Cr)
Net Sales - Quarterly
Lowest at Rs 22.18 cr
in the last five quartersMOJO Watch
Near term sales trend is negative
Net Sales (Rs Cr)
Earnings per Share (EPS) - Quarterly
Lowest at Rs 1.01
in the last five quartersMOJO Watch
Declining profitability; company has created lower earnings for shareholders
EPS (Rs)
InfinHub Market Technologies FZ-LLC, Building-2, Unit 112, Dubai Internet City, Dubai, United Arab Emirates
GET THE MARKETSMOJO APP
Company
Stocks
Portfolio
"Investment in securities markets are subject to market risk. Read all the related documents carefully before investing."
